levonorgestrel has been researched along with Cancer of Ovary in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (6.25) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 12 (75.00) | 24.3611 |
2020's | 3 (18.75) | 2.80 |
Authors | Studies |
---|---|
Chin, JPS; Mok, ZW | 1 |
Caldwell, A; Joseph, S; Landrum, LM; Minalt, N; Peipert, JF; Robertson, SE; Yedlicka, GM | 1 |
Joy, KM | 1 |
Barra, F; Costantini, S; D'Alessandro, G; Ferrero, S; Frigerio, M; Gustavino, C | 1 |
Aarflot, M; Braaten, T; Bøvelstad, HM; Jareid, M; Lund, E; Thalabard, JC | 1 |
Amat, L; Bulach, A; Leclercq, M; Mesrine, S; Scheffler, F; Scheffler, M; Sperandeo, D | 1 |
Alberts, DS; Bartels, PH; Basil, J; Hunn, J; Hurteau, J; Kauderer, J; Lele, S; Modesitt, SC; Rodriguez, GC; Russell, S; Thaete, LG; Watkin, WG; Yozwiak, M; Zhang, HH; Zivanovic, O | 1 |
Dyba, T; Koskela-Niska, V; Lyytinen, H; Pukkala, E; Ylikorkala, O | 1 |
Grénman, S; Hurskainen, R; Mäenpää, J; Paavonen, J; Pukkala, E; Soini, T | 2 |
Cho, YJ; Jung, YW; Kim, MK; Kim, ML; Seong, SJ; Yun, BS | 1 |
Curtis, KM; Marchbanks, PA; Whiteman, MK; Zapata, LB | 1 |
Bocciolone, L; Boveri, S; Casadio, C; Franchi, D; Minig, L; Sideri, M | 1 |
Jung, YW; Kim, JW; Seong, SJ | 1 |
Cutillas, N; Espinosa, A; Hannon, MJ; Rodríguez, V; Ruiz, J | 1 |
Huggins, GR; Wentz, AC | 1 |
4 review(s) available for levonorgestrel and Cancer of Ovary
Article | Year |
---|---|
Association between intrauterine device use and endometrial, cervical, and ovarian cancer: an expert review.
Topics: Cervix Uteri; Contraceptive Agents, Female; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Ovarian Neoplasms; Uterine Cervical Neoplasms | 2023 |
Contraception options for patients with known hereditary risk for ovarian cancer.
Topics: Adult; Contraceptives, Oral; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Ovarian Neoplasms; Prophylactic Surgical Procedures; Salpingectomy; Sterilization, Tubal; Young Adult | 2019 |
Systematic review and meta-analysis on the impact of the levonorgestrel-releasing intrauterine system in reducing risk of ovarian cancer.
Topics: Carcinoma, Ovarian Epithelial; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Ovarian Neoplasms | 2022 |
Intrauterine device use among women with ovarian cancer: a systematic review.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Ovarian Neoplasms | 2010 |
1 trial(s) available for levonorgestrel and Cancer of Ovary
Article | Year |
---|---|
Phase II Trial of Chemopreventive Effects of Levonorgestrel on Ovarian and Fallopian Tube Epithelium in Women at High Risk for Ovarian Cancer: An NRG Oncology Group/GOG Study.
Topics: Adult; Aged; Apoptosis; Cell Proliferation; Contraceptive Agents, Hormonal; Fallopian Tube Neoplasms; Female; Follow-Up Studies; Humans; Levonorgestrel; Middle Aged; Ovarian Neoplasms; Prognosis | 2019 |
11 other study(ies) available for levonorgestrel and Cancer of Ovary
Article | Year |
---|---|
Rare case of coexisting ovarian Brenner tumour and ovarian stromal hyperplasia presenting with persistent endometrial hyperplasia following treatment with levonorgestrel-intrauterine system.
Topics: Brenner Tumor; Endometrial Hyperplasia; Female; Humans; Hyperplasia; Intrauterine Devices, Medicated; Levonorgestrel; Ovarian Neoplasms | 2022 |
Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study.
Topics: Adult; Aged; Carcinoma, Ovarian Epithelial; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Endometrial Neoplasms; Female; Humans; Levonorgestrel; Middle Aged; Neoplasms, Glandular and Epithelial; Norway; Ovarian Neoplasms; Prospective Studies; Surveys and Questionnaires | 2018 |
[Additional non-contraceptive effects of contraception: CNGOF Contraception Guidelines].
Topics: Administration, Cutaneous; Administration, Intravaginal; Contraception; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Dysmenorrhea; Endometriosis; Female; France; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Ovarian Cysts; Ovarian Neoplasms; Pregnancy | 2018 |
Effect of various forms of postmenopausal hormone therapy on the risk of ovarian cancer--a population-based case control study from Finland.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Contraceptive Agents, Female; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Finland; Humans; Levonorgestrel; Middle Aged; Norpregnenes; Ovarian Neoplasms; Postmenopause; Progestins; Registries; Risk | 2013 |
Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland.
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Contraceptive Agents, Female; Endometrial Neoplasms; Female; Finland; Follow-Up Studies; Humans; Incidence; Intrauterine Devices, Medicated; Levonorgestrel; Lung Neoplasms; Menorrhagia; Middle Aged; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Registries | 2014 |
Impact of levonorgestrel-releasing intrauterine system use on the cancer risk of the ovary and fallopian tube.
Topics: Adult; Cohort Studies; Contraceptive Agents, Female; Fallopian Tube Neoplasms; Female; Finland; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Ovarian Neoplasms; Risk Factors | 2016 |
The efficacy of long-term maintenance therapy with a levonorgestrel-releasing intrauterine system for prevention of ovarian endometrioma recurrence.
Topics: Adult; Combined Modality Therapy; Contraceptives, Oral, Combined; Drug Administration Schedule; Endometriosis; Female; Humans; Levonorgestrel; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Republic of Korea; Retrospective Studies; Treatment Outcome; Young Adult | 2016 |
Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women.
Topics: Adult; Antineoplastic Agents, Hormonal; Drug Delivery Systems; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Gonadotropin-Releasing Hormone; Humans; Infertility; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Ovarian Neoplasms; Pregnancy; Prospective Studies; Recurrence; Treatment Outcome; Young Adult | 2011 |
Should diagnostic laparoscopy be conducted before hormonal treatment in early-stage endometrial cancer?
Topics: Antineoplastic Agents, Hormonal; Clinical Trials as Topic; Drug Therapy, Combination; Endometrial Neoplasms; Female; Gonadotropin-Releasing Hormone; Humans; Laparoscopy; Levonorgestrel; Neoplasms, Multiple Primary; Ovarian Neoplasms | 2011 |
A potent ruthenium(II) antitumor complex bearing a lipophilic levonorgestrel group.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Screening Assays, Antitumor; Female; Guanine; Humans; Levonorgestrel; Models, Molecular; Ovarian Neoplasms; Ruthenium | 2011 |
Obstetrics and gynecology.
Topics: Female; Gynecology; Humans; Infertility; Levonorgestrel; Medroxyprogesterone Acetate; Obstetrics; Ovarian Neoplasms; United States | 1993 |